HTA323 Analyzing Historic Health Technology Assessments (HTAs): Surrogate Endpoints (SEs) in the Interstitial Pneumonia With Autoimmune Features (IPF)/Interstitial Lung Disease (ILD) Therapeutic Domain
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.2006
https://www.valueinhealthjournal.com/article/S1098-3015(23)05136-7/fulltext
Title :
HTA323 Analyzing Historic Health Technology Assessments (HTAs): Surrogate Endpoints (SEs) in the Interstitial Pneumonia With Autoimmune Features (IPF)/Interstitial Lung Disease (ILD) Therapeutic Domain
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)05136-7&doi=10.1016/j.jval.2023.09.2006
First page :
Section Title :
Open access? :
No
Section Order :
11456